|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�Դ������� |
|
�ܲ� |
|
ɳ����ԭ�� |
|
���� |
| ��������������� | |
|
��Ң |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
�����ܲ��ϲ�ɳ����ԭ���Ⱦ��ҩ��ѡ��
��Ң, ��С��
����ҽ�ƴ�ѧ������һҽԺ, 400016
�ܲ��ϲ�ɳ����ԭ���Ⱦ�������кܶ�ҩ���ѡ��.��һ��ҩ�������ܶ����ֲ�ԭ������ȷ����Ч,������ҩ�������Ƶ���Ҫ�ֶ�.���������˦�-�������ࡢ�Ļ����ࡢ�������ࡢ����߰��ͷ��ŵͪ����������ɳ����ԭ��Ŀ�������,���Ƽ������������������ĵ���ҩ����.
[2] Paavonen J, Eggert-Kruse W. Chlamydia trachomatis;impact on human reproduction. Hum Reprod Update, 1999,5(5):433-447.
[3] FitzGerald M, Bedford C. National standards for the management of gonorrhoea. Int J STD AIDS, 1996,7(4):298-300.
[4] van Duynhoven YT. The epidemiology of Neisseria gonorrhoeae in Europe. Microbes Infect, 1999,1(6):455-464.
[5] Aplasca De Los Reyes MR, Pato-Mesola V, Klausner JD, et al. A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines. Clin Infect Dis, 2001, 32(9):1313-1318.
[6] Centers For Disease Control and Prevention. 2002 Guidelinse for treatment of sexually transmitted disease. MMWR Morb Mortal Wkly Rep,2002,51;No. RR-6.
[7] Horner PJ, Cain D, McClure M, et al. Association of antibodies to Chlamydia trachomatis heat-shock protein 60 kD with chronic nongonococcal urethritis. Clin Infect Dis,1997,24(4):653-660.
[8] Romanowski B, Talbot H, Stadnyk M, et al. Minocycline compared with doxycycline in the tieatment of nongonococcal urethritis and mucopurulent cervicitis. Ann Intern Med, 1993,119(1):16-22.
[9] Mikamo H, Sato Y, Hayasaki Y, et al. Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis.Chemotherapy, 1999,45(5):396-398.
[10] Radowicki S, Tyc M, Kulesza E, et al. Roxithromycin(Rulid) in treatment of Chlamydia trachomatis genital infections in women.Ginekol Pol, 1995,66(6):354-356.
[11] Handsfield HH, Dalu ZA, Martin DH, et al. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group. Sex Transm Dis,1994,21(2):107-111.
[12] Hammerschlag MR, Golden NH, Oh MK, et al. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents.J Pediatr,1993,122(6):961-965.
[13] Hillis SD, Coles FB, Litchfield B,et al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings. Sex Transm Dis,1998, 25(1):5-11.
[14] Lind I. Antimicrobial resistance in Neisseria gonorrhoeae. Clin Infect Dis,1997, 24(Suppl 1):S93-97.
[15] Peipert JF, Sweet RL, Walker CK, et al. Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease(salpingitis). Infect Dis Obstet Gynecol, 1999,7(3):138-144.
[16] Jones RB, Schwebke J, Thorpe EM Jr,et al. Randomized trial of tro-vafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group. Am J Med, 1998,104(1):28-32.
[17] Moi H, Morel P, Gianotti B,et al. Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men. J Antimicrob Chemother, 1996,37(Suppl A):115-122.
[18] Hook EW 3rd, McCormack WM, Martin D, et al. Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group. Antimicrob Agents Chemother, 1997,41(8):1843-1845.
[19] McCormack WM, Martin DH, Hook EW 3rd,et al. Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection. Infect Dis Obstet Gynecol, 1998,6(3):109-115.
[20] Biedenbach DJ, Beach ML, Jones RN. Antimicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolone-resistant strains. Diagn Microbiol Infect Dis,1998,32(4):307-311.
[21] No authors listed. Antimicrobial resistance in gonococci, WHO Western Pacific Region, 1996. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Commun Dis Intell,1997,21(23):349-353.